Class summary at a glance.

Every drug in the Sympathomimetic-like Agent class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 1tracked in Part D
CY24 Part D spend: $58.4Mcombined across class
Total Rx claims: 564K141K unique beneficiaries
Generic mfrs (active): 6across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Modafinil

Brand: Provigil · 564K Part D claims (CY24) · 141K beneficiaries · First FDA approval: 1998-12-24

6 generic mfrs 622 plans require PA

Low NADAC$0.258

→

Avg plan cost$5.96

Part D spend $58.4M 23× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.